Latest filing published 16 May 2024 for Atrys Health, S.A., €15k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Prestige Inversiones, SIL, S.A. on record concern Atrys Health, S.A. Over a trading history stretching from 10 May 2024 to 14 May 2024, the count stands at 5 filings.
Every open-market trade on record is a purchase: 5 purchases worth €143k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €15k and half below. Relative to company size, the median is 0.0071% of market cap (5 purchases with a known value). No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 16 May 2024, reports an open-market purchase of €15k in Atrys Health, S.A. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from CNMV. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations